You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

~ Buy the XARELTO (rivaroxaban) Drug Profile, 2024 PDF Report in the Report Store ~

Litigation for xarelto


✉ Email this page to a colleague

« Back to Dashboard


US Court Litigation for xarelto

Patent Trial and Appeal Board Cases for xarelto

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
7,157,456 Mylan Pharmaceuticals Inc et al. ⤷  Subscribe 2016-10-07 10-07-2016 Straub et al Inter partes review ⤷  Subscribe ⤷  Subscribe
7,585,860 Mylan Pharmaceuticals Inc. et al. ⤷  Subscribe 2016-10-07 10-07-2016 Straub et al Inter partes review ⤷  Subscribe ⤷  Subscribe
7,592,339 Mylan Pharmaceuticals Inc. et al. ⤷  Subscribe 2016-10-07 10-07-2016 Straub et al Inter partes review ⤷  Subscribe ⤷  Subscribe
9,539,218 ⤷  Subscribe 2014-01-30 201 ⤷  Subscribe ⤷  Subscribe
9,539,218 Mylan Pharmaceuticals Inc. et al. ⤷  Subscribe 2018-05-24 05-24-2018 Inter partes review ⤷  Subscribe 12-03-2018 ⤷  Subscribe
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.